Healthcare -
Biotechnology - NASDAQ - US
$ 25.535
2.55 %
$ 279 M
Market Cap
-1.07
P/E
CDTX - TOTAL RECEIVABLES
Total Receivables CDTX - Cidara Therapeutics, Inc.
16.2 M
LAST VALUE
74.16%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR